Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1951 1
1955 2
1956 1
1957 1
1958 1
1960 1
1961 2
1966 1
1967 3
1969 2
1970 2
1971 1
1974 4
1975 2
1976 1
1977 2
1978 1
1979 3
1981 7
1982 3
1983 3
1985 1
1986 8
1987 3
1988 4
1989 4
1990 3
1991 8
1992 6
1993 4
1994 5
1995 4
1996 2
1997 6
1998 4
1999 3
2000 9
2001 9
2002 7
2003 11
2004 15
2005 21
2006 16
2007 19
2008 20
2009 16
2010 22
2011 17
2012 26
2013 23
2014 33
2015 36
2016 27
2017 25
2018 27
2019 17
2020 16
2021 17
2022 20
2023 23
2024 14
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

539 results

Results by year

Filters applied: . Clear all
Page 1
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: pons a. J Clin Oncol. 2010 Jul 1;28(19):3167-75. doi: 10.1200/JCO.2009.26.7609. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516446 Free PMC article. Clinical Trial.
Association between early nutrition support and 28-day mortality in critically ill patients: the FRANS prospective nutrition cohort study.
Pardo E, Lescot T, Preiser JC, Massanet P, Pons A, Jaber S, Fraipont V, Levesque E, Ichai C, Petit L, Tamion F, Taverny G, Boizeau P, Alberti C, Constantin JM, Bonnet MP; FRANS study group. Pardo E, et al. Among authors: pons a. Crit Care. 2023 Jan 7;27(1):7. doi: 10.1186/s13054-022-04298-1. Crit Care. 2023. PMID: 36611211 Free PMC article.
Thoracic surgery in the UK.
Pons A, Lim E. Pons A, et al. J Thorac Dis. 2022 Feb;14(2):575-578. doi: 10.21037/jtd-21-1080. J Thorac Dis. 2022. PMID: 35280467 Free PMC article. No abstract available.
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
Singla N, Nirschl TR, Obradovic AZ, Shenderov E, Lombardo K, Liu X, Pons A, Zarif JC, Rowe SP, Trock BJ, Hammers HJ, Bivalacqua TJ, Pierorazio PM, Deutsch JS, Lotan TL, Taube JM, Ged YMA, Gorin MA, Allaf ME, Drake CG. Singla N, et al. Among authors: pons a. Sci Rep. 2024 Jan 17;14(1):1458. doi: 10.1038/s41598-024-51889-9. Sci Rep. 2024. PMID: 38228729 Free PMC article.
Coumarin and Derivates as Lipid Lowering Agents.
Tejada S, Martorell M, Capo X, Tur JA, Pons A, Sureda A. Tejada S, et al. Among authors: pons a. Curr Top Med Chem. 2017;17(4):391-398. doi: 10.2174/1568026616666160824102322. Curr Top Med Chem. 2017. PMID: 27558682 Review.
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: pons a. J Clin Oncol. 2023 Feb 1;41(4):715-723. doi: 10.1200/JCO.22.02270. J Clin Oncol. 2023. PMID: 36706735 Clinical Trial.
Effects of cataract surgery on blinking.
Talens-Estarelles C, Díez-Ajenjo MA, Pons ÁM, Peris-Martínez C, García-Lázaro S. Talens-Estarelles C, et al. Among authors: pons am. J Cataract Refract Surg. 2023 Feb 1;49(2):177-183. doi: 10.1097/j.jcrs.0000000000001081. J Cataract Refract Surg. 2023. PMID: 36255227
539 results